Table: Pharmarise Holdings - 6-MTH group results

Pharmarise Holdings

25/12/2023 08:00

Dec 25 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Nov 30, 2023        Nov 30, 2022     May 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               26.95               25.75            53.55    
                   (+4.7 pct)          (-0.6 pct)       (+2.9 pct)  
  Operating          710 mln             573 mln            1.48    
                   (+23.9 pct)         (-27.3 pct)      (+2.7 pct)  
  Recurring          701 mln             566 mln            1.42    
                   (+23.9 pct)         (-30.4 pct)      (-0.6 pct)  
  Net                273 mln             72 mln           449 mln   
                  (+276.6 pct)         (-71.0 pct)      (+34.9 pct) 
  EPS               28.29 yen           7.76 yen         41.99 yen  
  EPS Diluted       26.99 yen           5.93 yen                    
  Ann Div                               14.00 yen        20.00 yen  
  -Q2 div              NIL                 NIL                      
  -Q4 div                               14.00 yen        20.00 yen  
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T